We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Sekisui Diagnostics UK Ltd.

Download Mobile App




First-Of-Its-Kind Technology Platform Leverages Bacteriophages to Tackle Critical and Life-Threatening Infections

By HospiMedica International staff writers
Posted on 16 Jun 2023
Print article
Image: A world-first technology platform mobilizes natural power of bacteriophages to tackle serious infections (Photo courtesy of Freepik)
Image: A world-first technology platform mobilizes natural power of bacteriophages to tackle serious infections (Photo courtesy of Freepik)

The escalating global health crisis of antimicrobial resistance, referred to as 'the silent pandemic', is predicted by the World Health Organization (WHO) to account for 10 million deaths per year by 2050. Recognized by the WHO as one of the top 10 global health threats to mankind, drug-resistant infections have already caused more than 5 million deaths worldwide. Now, a world-first technology platform that leverages the innate power of bacteriophages, viruses that infect and destroy bacteria, to eliminate critical and life-threatening infections marks a significant medical breakthrough for countering the global threat of antimicrobial resistance.

Bacteriophages, also called phages, are naturally occurring viruses that have been battling bacteria throughout evolution. They are capable of infiltrating and destroying bacterial colonies with unerring precision. While phages have been deployed in human treatments for over a century, their full medical potential remains untapped. PHIOGEN (Houston, TX, USA) has developed an innovative platform that capitalizes on the successes of personalized phage therapy. PHIOGEN is a spin-off company from Baylor College of Medicine’s TAILOR Labs (Houston, TX, USA), one of the United States' only academic phage therapy cores with a decade’s worth of revolutionary research related to bacteriophages. PHIOGEN’s innovative platform leverages the successes of personalized phage therapy. The platform empowers PHIOGEN to identify unique phages with targeted neutralizing abilities, evolve hyper-lytic phages to counter resistance and test them in high-throughput biological models. The result is cultivated antimicrobial solutions that successfully productize bacteriophages to enhance clinical outcomes.

PHIOGEN has developed the world's only bacteriophage mass capture device, allowing the company to undertake phage reconnaissance missions, and collect and filter billions of phages from their natural environments, thereby reducing sample collection time from four days to just under four hours. PHIOGEN’s proprietary first-of-its-kind technology platform can discover and screen naturally occurring bacteriophages on a large scale, identifying those with superior bacterial combat abilities. It can then facilitate biological changes to evolve these phages into antimicrobials capable of overcoming resistance. This enables the creation of treatments for large populations rather than individual patients. By refining nature's guardians, PHIOGEN has developed extraordinary phage treatments that have already successfully saved numerous lives in FDA-approved compassionate use cases.

“Nothing about our treatments is fabricated, it boils down to creating natural environments that mimic real-life infections, driving biological changes to create "super phages” against the superbugs,” said Amanda Burkardt, CEO at PHIOGEN. “As a result, we receive high-performing phage fighters that are trained and ready to deliver safe and effective treatments for clinical applications.”

“Our patented technique of evolving the natural fighting power of bacteriophages creates a new paradigm in phage therapy where natural lytic cocktails carry the same advantages as fully synthetic phage and can be used to treat entire patient populations,” added Burkardt.

Related Links:
PHIOGEN 
Baylor College of Medicine 

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Silver Member
Wireless Mobile ECG Recorder
NR-1207-3/NR-1207-E
New
Digital Radiography Generator
meX+20BT lite

Print article

Channels

Surgical Techniques

view channel
Image: LUMISIGHT and Lumicell DVS offer 84% diagnostic accuracy in detecting residual cancer (Photo courtesy of Lumicell)

Cutting-Edge Imaging Platform Detects Residual Breast Cancer Missed During Lumpectomy Surgery

Breast cancer is becoming increasingly common, with statistics indicating that 1 in 8 women will develop the disease in their lifetime. Lumpectomy remains the predominant surgical intervention for treating... Read more

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.